Advances in immunotherapy of advanced non-small cell lung cancer with EGFR mutation

The incidence of epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC) in Asians is significantly higher than that in Westerners. For the past few years, immune checkpoint inhibitors (ICIs) that target the programmed cell death 1 (PD-1) /programmed cell death ligand...

Full description

Bibliographic Details
Main Authors: HUANG Huayan, XU-ZHANG Wendi, XIA Liliang, YU Yongfeng, LU Shun
Format: Article
Language:zho
Published: Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2023-05-01
Series:Shanghai Jiaotong Daxue xuebao. Yixue ban
Subjects:
Online Access:https://xuebao.shsmu.edu.cn/article/2023/1674-8115/1674-8115-2023-43-5-611.shtml

Similar Items